Latest Klaria News & Updates

See the latest news and media coverage for Klaria. We track all announcements, press releases, and industry mentions in real time, all in one place.

Klaria

Pharmaceutical developer using alginate film technology

klariapharma.se

Headquarters: Uppsala Businesspark, Sweden
Founded year: 2015
Company type: Public company
Number of employees: 8–10
Industry: Pharmaceuticals

Last updated Yesterday

Latest news about Klaria

In short: Klaria secured 75% backing for its 148 MSEK rights issue and a $500M peak sales valuation.

Company announcements

Yesterday Klaria

Klaria advances licensing agreement and strategic process

Approaching European launch of migraine product SAF with CNX and completed strategic plan for the US. BDO's M&A collaboration is accelerating to maximize shareholder value.

October 22 Klaria

Klaria extends the issuance and receives new commitments

The company receives approximately 2.2 MSEK without pre-emptive rights and extends the subscription period to November 6, 2026 due to strong interest.

October 13 Klaria

Klaria announces prospectus for rights issue

The Finnish Financial Supervisory Authority approves the EU prospectus in connection with an issue of approximately SEK 147.6 million. The subscription period runs from October 14 to 28, 2026.

October 5 Klaria

Klaria resolves rights offering and charter amendments

The company approved a max 61.5M unit rights offering at SEK 2.40, authorized board to issue warrants for guarantees, and updated share capital limits.

Media coverage

October 18 AffärsVärlden

Klaria's new issuance: Only 29 of 148 million to the treasury

The majority of Klaria Pharma's preferred share issuance goes towards paying off or offsetting debts, including two bridge loans. Emissionsguiden raises five...

October 8 Zone Bourse

Klaria Pharma obtains commitments covering 75% of its rights issue of 148 million Swedish krona

— Klaria Pharma Holding has obtained subscription and guarantee commitments totaling 111.1 million krona, representing 75.3% of its issuance of...

September 30 AffärsVärlden

Klaria's report overstated the securing in the new issue

Klaria Pharma is conducting a pre-emptive rights issue that could bring in SEK 148 million before costs. The Q2 report initially stated that 74% was secured, but the correct figure was...

September 1 Zone Bourse

Klaria Pharma Holding AB (publ.) publishes its results for the second quarter and the half-year ended June 30, 2026

Klaria Pharma Holding AB has published its financial results for the second quarter and the half-year ended June 30, 2026. For the second quarter...

Never miss news about Klaria

Track Klaria and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Klaria competitors & trending companies

Browse news for competitors to Klaria and other trending companies.